Market News

Tourbillon Capital Partners LP Lifted Incyte (INCY) Position by $3.72 Million; Benchmark Capital Advisors Has Lowered Its Pfizer (PFE) Holding by $381,600

Pfizer Inc. (NYSE:PFE) Logo

Jason Karp increased its stake in Incyte Corp (INCY) by 15.53% based on its latest 2017Q4 regulatory filing with the SEC. Tourbillon Capital Partners Lp bought 39,607 shares as the company’s stock declined 11.25% with the market. The hedge fund run by Jason Karp held 294,607 shares of the commercial physical & biological resarch company at the end of 2017Q4, valued at $27.90 million, up from 255,000 at the end of the previous reported quarter. Tourbillon Capital Partners Lp who had been investing in Incyte Corp for a number of months, seems to be bullish on the $14.38B market cap company. The stock increased 1.79% or $1.19 during the last trading session, reaching $67.83. About 1.46M shares traded. Incyte Corporation (NASDAQ:INCY) has declined 39.22% since May 20, 2017 and is downtrending. It has underperformed by 50.77% the S&P500.

Benchmark Capital Advisors decreased its stake in Pfizer Inc. (PFE) by 9.58% based on its latest 2017Q4 regulatory filing with the SEC. Benchmark Capital Advisors sold 10,600 shares as the company’s stock declined 3.13% with the market. The institutional investor held 100,075 shares of the health care company at the end of 2017Q4, valued at $3.63M, down from 110,675 at the end of the previous reported quarter. Benchmark Capital Advisors who had been investing in Pfizer Inc. for a number of months, seems to be less bullish one the $208.48B market cap company. The stock decreased 0.20% or $0.07 during the last trading session, reaching $35.64. About 14.93M shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since May 20, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

Tourbillon Capital Partners Lp, which manages about $1.12 billion and $2.70B US Long portfolio, decreased its stake in Sunopta Inc (NASDAQ:STKL) by 3.70M shares to 4.16 million shares, valued at $32.27 million in 2017Q4, according to the filing. It also reduced its holding in Post Hldgs Inc (NYSE:POST) by 953,823 shares in the quarter, leaving it with 125,185 shares, and cut its stake in Spdr S&P 500 Etf Tr (Put) (SPY).

Among 27 analysts covering Incyte (NASDAQ:INCY), 20 have Buy rating, 0 Sell and 7 Hold. Therefore 74% are positive. Incyte had 91 analyst reports since August 6, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, August 12 by Zacks. RBC Capital Markets initiated the stock with “Outperform” rating in Wednesday, July 13 report. The rating was maintained by Oppenheimer with “Hold” on Wednesday, July 5. The rating was maintained by Oppenheimer with “Hold” on Tuesday, August 1. Gabelli downgraded the stock to “Hold” rating in Monday, April 9 report. The stock has “Buy” rating by BMO Capital Markets on Sunday, August 27. Raymond James upgraded the stock to “Outperform” rating in Thursday, September 29 report. Oppenheimer maintained Incyte Corporation (NASDAQ:INCY) on Tuesday, July 25 with “Hold” rating. The rating was maintained by Jefferies with “Buy” on Wednesday, October 4. As per Tuesday, August 18, the company rating was maintained by Cowen & Co.

Since January 5, 2018, it had 1 insider purchase, and 4 sales for $5.08 million activity. Huber Reid M had sold 1,958 shares worth $167,507 on Tuesday, February 20. Hoppenot Herve had bought 15,000 shares worth $914,100 on Wednesday, May 2. 1,952 shares valued at $167,013 were sold by GRYSKA DAVID W on Tuesday, February 20.

Investors sentiment increased to 1.06 in Q4 2017. Its up 0.02, from 1.04 in 2017Q3. It increased, as 59 investors sold INCY shares while 141 reduced holdings. 59 funds opened positions while 153 raised stakes. 191.73 million shares or 1.46% more from 188.97 million shares in 2017Q3 were reported. Brown Advisory Inc accumulated 0% or 7,223 shares. Natixis holds 0.01% in Incyte Corporation (NASDAQ:INCY) or 7,680 shares. The New York-based Amer Intll Gp has invested 0.02% in Incyte Corporation (NASDAQ:INCY). Clearbridge Lc reported 84,661 shares. Nordea Investment Ab owns 8,110 shares for 0% of their portfolio. Great Lakes Advisors holds 0.02% in Incyte Corporation (NASDAQ:INCY) or 7,269 shares. Arizona State Retirement Sys has invested 0.04% in Incyte Corporation (NASDAQ:INCY). Moreover, Glob X Co Ltd has 0.03% invested in Incyte Corporation (NASDAQ:INCY). Institute For Wealth Management Ltd Liability Corporation has invested 0.11% of its portfolio in Incyte Corporation (NASDAQ:INCY). Rampart Mgmt Ltd Co reported 2,123 shares stake. Verition Fund Mgmt Ltd Liability Co holds 0.07% of its portfolio in Incyte Corporation (NASDAQ:INCY) for 8,083 shares. Tirschwell Loewy reported 0.1% stake. Franklin has 0.12% invested in Incyte Corporation (NASDAQ:INCY). 66,047 are held by Macquarie Grp Ltd. Twin Tree Mgmt LP holds 0% or 1,497 shares in its portfolio.

More recent Incyte Corporation (NASDAQ:INCY) news were published by: Globenewswire.com which released: “Detailed Research: Economic Perspectives on Voya Financial, Dominion Energy, Incyte, MeetMe, Ventas, and Select …” on May 10, 2018. Also Schaeffersresearch.com published the news titled: “2 Drug Stocks Slammed By FDA” on April 24, 2018. Bizjournals.com‘s news article titled: “Big Peninsula biotech buyout means happy returns for Kleiner Perkins, other VCs” with publication date: May 10, 2018 was also an interesting one.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on August, 7. They expect $0.75 earnings per share, up 11.94% or $0.08 from last year’s $0.67 per share. PFE’s profit will be $4.39B for 11.88 P/E if the $0.75 EPS becomes a reality. After $0.77 actual earnings per share reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -2.60% negative EPS growth.

Among 22 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 12 Hold. Therefore 41% are positive. Pfizer had 79 analyst reports since July 29, 2015 according to SRatingsIntel. BMO Capital Markets downgraded the stock to “Market Perform” rating in Wednesday, November 2 report. The company was maintained on Friday, August 28 by Piper Jaffray. The firm has “Neutral” rating by Suntrust Robinson given on Wednesday, November 25. Piper Jaffray maintained Pfizer Inc. (NYSE:PFE) on Friday, August 14 with “Buy” rating. The stock has “Hold” rating by Jefferies on Wednesday, August 16. The stock of Pfizer Inc. (NYSE:PFE) earned “Equal-Weight” rating by Barclays Capital on Tuesday, December 1. BMO Capital Markets maintained Pfizer Inc. (NYSE:PFE) on Tuesday, September 5 with “Buy” rating. Cowen & Co maintained Pfizer Inc. (NYSE:PFE) on Monday, July 10 with “Buy” rating. Jefferies maintained Pfizer Inc. (NYSE:PFE) rating on Tuesday, September 13. Jefferies has “Buy” rating and $39 target. Leerink Swann maintained it with “Market Perform” rating and $38 target in Wednesday, January 31 report.

Since December 15, 2017, it had 0 buys, and 13 selling transactions for $17.75 million activity. On Wednesday, February 28 the insider HILL CHARLES H sold $986,292. 9,510 Pfizer Inc. (NYSE:PFE) shares with value of $353,677 were sold by LUND-JURGENSEN KIRSTEN. 13,986 Pfizer Inc. (NYSE:PFE) shares with value of $501,398 were sold by Dolsten Mikael. MACKENZIE ALEXANDER R sold $249,750 worth of Pfizer Inc. (NYSE:PFE) on Friday, December 15. CORNWELL W DON also sold $64,679 worth of Pfizer Inc. (NYSE:PFE) shares. Shares for $4.76M were sold by READ IAN C.

Investors sentiment increased to 1.06 in Q4 2017. Its up 0.10, from 0.96 in 2017Q3. It improved, as 51 investors sold PFE shares while 675 reduced holdings. 134 funds opened positions while 632 raised stakes. 4.07 billion shares or 0.28% more from 4.06 billion shares in 2017Q3 were reported. Parsec Management, North Carolina-based fund reported 13,153 shares. Cutler Cap Mgmt Ltd stated it has 0.57% in Pfizer Inc. (NYSE:PFE). Tdam Usa holds 425,550 shares. Madison Inv accumulated 615,293 shares. Reliance Tru Of Delaware accumulated 93,947 shares. Institute For Wealth Mgmt Ltd Liability Corporation stated it has 42,186 shares or 0.35% of all its holdings. Wunderlich Managemnt has 1.08% invested in Pfizer Inc. (NYSE:PFE) for 43,196 shares. Pettyjohn Wood White Incorporated invested in 0.97% or 74,341 shares. Opus Capital Gp Ltd Limited Liability Company reported 20,798 shares. Brown Brothers Harriman And Company accumulated 307,124 shares. Utah Retirement System has 0.84% invested in Pfizer Inc. (NYSE:PFE) for 1.10 million shares. Wharton Business Group Inc Ltd Co owns 10,070 shares. Sterling Cap Ltd Co holds 0.66% or 2.02 million shares. Westwood Hldgs Grp Incorporated invested 0.01% in Pfizer Inc. (NYSE:PFE). Schnieders Ltd holds 1.02% or 68,233 shares in its portfolio.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: 247Wallst.com which released: “How Much Pfizer Earnings Depend on a Few Brands” on May 01, 2018, also Streetinsider.com with their article: “Pfizer (PFE) Announces FDA Approval for Biosimilar RETACRIT” published on May 15, 2018, 247Wallst.com published: “What to Look For in the Merck and Pfizer Reports Tuesday Morning” on April 30, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Fool.com and their article: “Better Buy: Pfizer Inc. (PFE) vs. Merck (MRK)” published on May 13, 2018 as well as Seekingalpha.com‘s news article titled: “Pfizer Is A Definite Buy For 2018” with publication date: April 30, 2018.

Incyte Corporation (NASDAQ:INCY) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *